Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'MPTP' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 1299 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Bezard, E; Brotchie, JM; Gross, CE
      Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies

      NATURE REVIEWS NEUROSCIENCE
    2. Beal, MF
      Experimental models of Parkinson's disease

      NATURE REVIEWS NEUROSCIENCE
    3. Kunugi, H; Ishida, S; Akahane, A; Nanko, S
      Exon/intron boundaries, novel polymorphisms, and association analysis withschizophrenia of the human synaptic vesicle monoamine transporter (SVMT) gene

      MOLECULAR PSYCHIATRY
    4. Tsang, KL; Jiang, H; Ramsden, DB; Ho, SL
      The use of estrogen in the treatment of Parkinson's disease

      PARKINSONISM & RELATED DISORDERS
    5. Naoi, M; Maruyama, W
      Future of neuroprotection in Parkinson's disease

      PARKINSONISM & RELATED DISORDERS
    6. Fredriksson, A; Schroder, N; Eriksson, P; Izquierdo, I; Archer, T
      Neonatal iron potentiates adult MPTP-induced neurodegenerative and functional deficits

      PARKINSONISM & RELATED DISORDERS
    7. Ghatani, T; Agapito, C; Bhattacharya, KF; Clough, C; Chaudhuri, KR
      Comparative audit of pergolide and cabergoline therapy in the treatment ofnocturnal 'off' periods causing sleep disruption in Parkinson's disease

      EUROPEAN JOURNAL OF NEUROLOGY
    8. Vila, M; Jackson-Lewis, V; Guegan, C; Wu, DC; Teismann, P; Choi, DK; Tieu, K; Przedborski, S
      The role of glial cells in Parkinson's disease

      CURRENT OPINION IN NEUROLOGY
    9. Stromberg, I; Tornqvist, N; Johansson, S; Bygdeman, M; Almqvist, PM
      Evidence for target-specific outgrowth from subpopulations of grafted human dopamine neurons

      MICROSCOPY RESEARCH AND TECHNIQUE
    10. Crofts, HS; Dalley, JW; Collins, P; Van Denderen, JCM; Everitt, BJ; Robbins, TW; Roberts, AC
      Differential effects of 6-OHDA lesions of the frontal cortex and caudate nucleus on the ability to acquire an attentional set

      CEREBRAL CORTEX
    11. Leung, DS; Unsicker, K; Reuss, B
      Gap junctions modulate survival-promoting effects of fibroblast growth factor-2 on cultured midbrain dopaminergic neurons

      MOLECULAR AND CELLULAR NEUROSCIENCE
    12. Almirall, H; Bautista, V; Sanchez-Bahillo, A; Trinidad-Herrero, M
      Ultradian and circadian body temperature and activity rhythms in chronic MPTP treated monkeys

      NEUROPHYSIOLOGIE CLINIQUE-CLINICAL NEUROPHYSIOLOGY
    13. Bezard, E; Ravenscroft, P; Gross, CE; Crossman, AR; Brotchie, JM
      Upregulation of striatal preproenkephalin gene expression occurs before the appearance of parkinsonian signs in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys

      NEUROBIOLOGY OF DISEASE
    14. Kuttab, S; Shang, J; Castagnoli, N
      Rat liver microsomal enzyme catalyzed oxidation of 4-phenyl-trans-1-(2-phenylcyclopropyl)-1,2,3,6-tetrahydropyridine

      BIOORGANIC & MEDICINAL CHEMISTRY
    15. Fukuhara, Y; Takeshima, T; Kashiwaya, Y; Shimoda, K; Ishitani, R; Nakashima, K
      GAPDH knockdown rescues mesencephalic dopaminergic neurons from MPP+-induced apoptosis

      NEUROREPORT
    16. Teismann, P; Schwaninger, M; Weih, F; Ferger, B
      Nuclear factor-kappa B activation is not involved in a MPTP model of Parkinson's disease

      NEUROREPORT
    17. Dluzen, DE; McDermott, JL; Anderson, LI
      Tamoxifen diminishes methamphetamine-induced striatal dopamine depletion in intact female and male mice

      JOURNAL OF NEUROENDOCRINOLOGY
    18. Iravani, MM; Costa, S; Jackson, MJ; Tel, BC; Cannizzaro, C; Pearce, RKB; Jenner, P
      GDNF reverses priming for dyskinesia in MPTP-treated, L-DOPA-primed commonmarmosets

      EUROPEAN JOURNAL OF NEUROSCIENCE
    19. Adams, JD; Chang, ML; Klaidman, L
      Parkinson's disease - Redox mechanisms

      CURRENT MEDICINAL CHEMISTRY
    20. Tonder, JE; Olesen, PH
      Agonists at the alpha 4 beta 2 nicotinic acetylcholine receptors: Structure-activity relationships and molecular modelling

      CURRENT MEDICINAL CHEMISTRY
    21. Araki, T; Mikami, T; Tanji, H; Matsubara, M; Imai, Y; Mizugaki, M; Itoyama, Y
      Biochemical and immunohistological changes in the brain of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mouse

      EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
    22. Araki, T; Mizutani, H; Matsubara, M; Imai, Y; Mizugaki, M; Itoyama, Y
      Nitric oxide synthase inhibitors cause motor deficits in mice

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    23. Smeyne, M; Goloubeva, O; Smeyne, RJ
      Strain-dependent susceptibility to MPTP and MPP+-induced parkinsonism is determined by glia

      GLIA
    24. Mushiroda, T; Ariyoshi, N; Yokoi, T; Takahara, E; Nagata, O; Kato, H; Kamataki, T
      Accumulation of the 1-methyl-4-phenylpyridinium ion in suncus (Suncus murinus) brain: Implication for flavin-containing monooxygenase activity in brain microvessels

      CHEMICAL RESEARCH IN TOXICOLOGY
    25. Cumming, P; Munk, OL; Doudet, D
      Loss of metabolites from monkey striatum during PET with FDOPA

      SYNAPSE
    26. Frechilla, D; Cobreros, A; Saldise, L; Moratalla, R; Insausti, R; Luquin, MR; Del Rio, J
      Serotonin 5-HT1A receptor expression is selectively enhanced in the striosomal compartment of chronic parkinsonian monkeys

      SYNAPSE
    27. Maratos, EC; Jackson, MJ; Pearce, RKB; Jenner, P
      Antiparkinsonian activity and dyskinesia risk of ropinirole and L-DOPA combination therapy in drug naive MPTP-lesioned common marmosets (Callithrix jacchus)

      MOVEMENT DISORDERS
    28. Fox, SH; Henry, B; Hill, MP; Peggs, D; Crossman, AR; Brotchie, JM
      Neural mechanisms underlying peak-dose dyskinesia induced by levodopa and apomorphine are distinct: Evidence from the effects of the alpha(2) adrenoceptor antagonist idazoxan

      MOVEMENT DISORDERS
    29. Rascol, O; Arnulf, I; Paul, HPS; Brefel-Courbon, C; Vidailhet, M; Thalamas, C; Bonnet, AM; Descombes, S; Bejjani, B; Fabre, N; Montastruc, JL; Agid, Y
      Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease

      MOVEMENT DISORDERS
    30. Turmel, H; Hartmann, A; Parain, K; Douhou, A; Srinivasan, A; Agid, Y; Hirsch, EC
      Caspase-3 activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice

      MOVEMENT DISORDERS
    31. Petzinger, GM; Quik, M; Ivashina, E; Jakowec, MW; Jakubiak, M; Di Monte, D; Langston, JW
      Reliability and validity of a new global dyskinesia rating scale in the MPTP-lesioned non-human primate

      MOVEMENT DISORDERS
    32. Barlas, O; Hanagasi, HA; Imer, M; Sahin, HA; Sencer, S; Emre, M
      Do unilateral ablative lesions of the subthalamic nucleu in Parkinsonian patients lead to hemiballism?

      MOVEMENT DISORDERS
    33. Rabasseda, X; Sorbera, LA; Martin, L; Leeson, PA; Castaner, J
      KW-6002 - Antiparkinsonian - Antidepressant - Adenosine A(2A) antagonist

      DRUGS OF THE FUTURE
    34. Guo, M; Chen, SD; Liu, ZG; Chen, HZ
      Eldepryl prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced nigral neuronal apoptosis in mice

      CHINESE MEDICAL JOURNAL
    35. Gevaerd, MS; Takahashi, RN; Silveira, R; Da Cunha, C
      Caffeine reverses the memory disruption induced by intra-nigral MPTP-injection in rats

      BRAIN RESEARCH BULLETIN
    36. Tariq, M; Khan, HA; Al Moutaery, K; Al Deeb, S
      Protective effect of quinacrine on striatal dopamine levels in 6-OHDA and MPTP models of Parkinsonism in rodents

      BRAIN RESEARCH BULLETIN
    37. Rothblat, DS; Schroeder, JA; Schneider, JS
      Tyrosine hydroxylase and dopamine transporter expression in residual dopaminergic neurons: Potential contributors to spontaneous recovery from experimental Parkinsonism

      JOURNAL OF NEUROSCIENCE RESEARCH
    38. Shimoke, K; Chiba, H
      Nerve growth factor prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced cell death via the Akt pathway by suppressing caspase-3-like activity using PC12 cells: Relevance to therapeutical application for Parkinson'sdisease

      JOURNAL OF NEUROSCIENCE RESEARCH
    39. Maruyama, Y; Suzuki, Y; Kazusaka, A; Fujita, S
      Uptake of the dopaminergic neurotoxin, norsalsolinol, into PC12 cells via dopamine transporter

      ARCHIVES OF TOXICOLOGY
    40. Tass, PA
      Desynchronizing double-pulse phase resetting and application to deep brainstimulation

      BIOLOGICAL CYBERNETICS
    41. Magill, PJ; Bolam, JP; Bevan, MD
      Dopamine regulates the impact of the cerebral cortex on the subthalamic nucleus-globus pallidus network

      NEUROSCIENCE
    42. Gao, X; Dluzen, DE
      Tamoxifen abolishes estrogen's neuroprotective effect upon methamphetamineneurotoxicity of the nigrostriatal dopaminergic system

      NEUROSCIENCE
    43. Bezard, E; Boraud, T; Chalon, S; Brotchie, JM; Guilloteau, D; Gross, CE
      Pallidal border cells: An anatomical and electrophysiological study in the1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkey

      NEUROSCIENCE
    44. Chen, JYR; Hsu, PC; Hsu, IL; Yeh, GC
      Sequential up-regulation of the c-fos, c-jun and bax genes in the cortex, striatum and cerebellum induced by a single injection of a low dose of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in C57BL/6 mice

      NEUROSCIENCE LETTERS
    45. Barc, S; Page, G; Barrier, L; Piriou, A; Fauconneau, B
      Impairment of the neuronal dopamine transporter activity in MPP+-treated rat was not prevented by treatments with nitric oxide synthase or poly(ADP-ribose) polymerase inhibitors

      NEUROSCIENCE LETTERS
    46. Hirata, Y; Kiuchi, K; Nagatsu, T
      Manganese mimics the action of 1-methyl-4-phenylpyridinium ion, a dopaminergic neurotoxin, in rat striatal tissue slices

      NEUROSCIENCE LETTERS
    47. Obata, T; Kubota, S; Yamanaka, Y
      Allopurinol suppresses para-nonylphenol and 1-methyl-4-phenylpyridinium ion (MPP+)-induced hydroxyl radical generation in rat striatum

      NEUROSCIENCE LETTERS
    48. Marcotte, ER; Chugh, A; Barlas, C; Mishra, RK
      Differential regulation of striatal G protein levels following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration in C57BL/6 mice

      NEUROSCIENCE LETTERS
    49. Blum, D; Torch, S; Lambeng, N; Nissou, MF; Benabid, AL; Sadoul, R; Verna, JM
      Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease

      PROGRESS IN NEUROBIOLOGY
    50. Garcia-Segura, LM; Azcoitia, I; DonCarlos, LL
      Neuroprotection by estradiol

      PROGRESS IN NEUROBIOLOGY
    51. Uezono, T; Matsubara, K; Shimizu, K; Mizukami, H; Ogawa, K; Saito, O; Hayase, N; Eto, H; Kimura, K; Shiono, H
      Glutamate is not involved in the MPP+-induced dopamine overflow in the striatum of freely moving C57BL/6 mice

      JOURNAL OF NEURAL TRANSMISSION
    52. Zeng, BY; Pearce, RKB; MacKenzie, GM; Jenner, P
      Chronic high dose L-dopa treatment does not alter the levels of dopamine D-1, D-2 or D-3 receptor in the striatum of normal monkeys: an autoradiographic study

      JOURNAL OF NEURAL TRANSMISSION
    53. Kupsch, A; Sautter, J; Gotz, ME; Breithaupt, W; Schwarz, J; Youdim, MBH; Riederer, P; Gerlach, M; Oertel, WH
      Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline

      JOURNAL OF NEURAL TRANSMISSION
    54. Fredriksson, A; Danysz, W; Quack, G; Archer, T
      Co-administration of memantine and amantadine with sub/suprathreshold doses of L-Dopa restores motor behaviour of MPTP-treated mice

      JOURNAL OF NEURAL TRANSMISSION
    55. Schmidt, N; Ferger, B
      Neurochemical findings in the MPTP model of Parkinson's disease

      JOURNAL OF NEURAL TRANSMISSION
    56. Mitsumoto, Y; Watanabe, A; Miyauchi, T; Jimma, F; Moriizumi, T
      Stimulation of the regrowth of MPP+-damaged dopaminergic fibers by the treatment of mesencephalic cultures with basigin - Short communication

      JOURNAL OF NEURAL TRANSMISSION
    57. Klein, BG; Kirby, ML; Freeborn, ER; Bloomquist, JR
      Pharmacological properties of the MPTP analog trans-1-methyl-4-[4-dimethylaminophenylethenyl]-1,2,3,6-tetrahydropyridine and its pyridinium metabolite in mouse brain synaptosomes: a potential visual marker for substrates of MPTP-induced neurotoxicity

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    58. Ongini, E; Monopoli, A; Impagnatiello, F; Fredduzzi, S; Schwarzschild, M; Chen, JF
      Dual actions of A(2A) adenosine receptor antagonists on motor dysfunction and neurodegenerative processes

      DRUG DEVELOPMENT RESEARCH
    59. Subramanian, T
      Cell transplantation for the treatment of Parkinson's disease

      SEMINARS IN NEUROLOGY
    60. Poyot, T; Conde, F; Gregoire, MC; Frouin, V; Coulon, C; Fuseau, C; Hinnen, F; Dolle, F; Hantraye, P; Bottlaender, M
      Anatomic and biochemical correlates of the dopamine transporter ligand C-11-PE2I in normal and parkinsonian primates: Comparison with 6-[F-18] Fluoro-L-Dopa

      JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    61. Mooslehner, KA; Chan, PM; Xu, WM; Liu, LZ; Smadja, C; Humby, T; Allen, ND; Wilkinson, LS; Emson, PC
      Mice with very low expression of the vesicular monoamine transporter 2 gene survive into adulthood: Potential mouse model for parkinsonism

      MOLECULAR AND CELLULAR BIOLOGY
    62. Zwart, R; Verhaagh, S; Buitelaar, M; Popp-Snijders, C; Barlow, DP
      Impaired activity of the extraneuronal monoamine transporter system known as uptake-2 in Orct3/Slc22a3-deficient mice

      MOLECULAR AND CELLULAR BIOLOGY
    63. Hartmann, A; Troadec, JD; Hunot, S; Kikly, K; Faucheux, BA; Mouatt-Prigent, A; Ruberg, M; Agid, Y; Hirsch, EC
      Caspase-8 is an effector in apoptotic death of dopaminergic neurons in Parkinson's disease, but pathway inhibition results in neuronal necrosis

      JOURNAL OF NEUROSCIENCE
    64. Brown, P; Oliviero, A; Mazzone, P; Insola, A; Tonali, P; Di Lazzaro, V
      Dopamine dependency of oscillations between subthalamic nucleus and pallidum in Parkinson's disease

      JOURNAL OF NEUROSCIENCE
    65. Bezard, E; Dovero, S; Prunier, C; Ravenscroft, P; Chalon, S; Guilloteau, D; Crossman, AR; Bioulac, B; Brotchie, JM; Gross, CE
      Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease

      JOURNAL OF NEUROSCIENCE
    66. Tseng, KY; Kasanetz, F; Kargieman, L; Riquelme, LA; Murer, MG
      Cortical slow oscillatory activity is reflected in the membrane potential and spike trains of striatal neurons in rats with chronic nigrostriatal lesions

      JOURNAL OF NEUROSCIENCE
    67. Quik, M; Polonskaya, Y; Kulak, JM; McIntosh, JM
      Vulnerability of I-125-alpha-conotoxin MII binding sites to nigrostriatal damage in monkey

      JOURNAL OF NEUROSCIENCE
    68. Wade, TV; Schneider, JS
      Expression of striatal preprotachykinin mRNA in symptomatic and asymptomatic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-exposed monkeys is related to parkinsonian motor signs

      JOURNAL OF NEUROSCIENCE
    69. Barc, S; Page, G; Fauconneau, B; Barrier, L; Huguet, F
      A new in vitro approach for investigating the MPTP effect on DA uptake

      NEUROCHEMISTRY INTERNATIONAL
    70. Hurley, MJ; Mash, DC; Jenner, P
      Dopamine D-1 receptor expression in human basal ganglia and changes in Parkinson's disease

      MOLECULAR BRAIN RESEARCH
    71. Kitamura, Y; Sanada, H; Kakimura, J; Ishida, Y; Shimohama, S; Taniguchi, T
      Decrease of tyrosine hydroxylase-, alpha-synuclein- and parkin-expressing neurons in the substantia nigra of MPTP-treated C57BL/6N mice

      BIOGENIC AMINES
    72. Kumagai, T; Ido, T; Araki, T; Matsubara, M; Imai, Y
      Riluzole protects against MPTP-induced dopamine and DOPAC depletion in mice

      BIOGENIC AMINES
    73. Ren, MQ; Xie, JP; Wang, XS; Ong, WY; Leong, SK; Watt, F
      Iron concentrations and distributions in the parkinsonian substantia nigraof aged and young primate models

      NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS
    74. Park, KW; Eglitis, MA; Mouradian, MM
      Protection of nigral neurons by GDNF-engineered marrow cell transplantation

      NEUROSCIENCE RESEARCH
    75. Sedelis, M; Schwarting, RKW; Huston, JP
      Behavioral phenotyping of the MPTP mouse model of Parkinson's disease

      BEHAVIOURAL BRAIN RESEARCH
    76. Da Cunha, C; Gevaerd, MS; Vital, MABF; Miyoshi, E; Andreatini, R; Silveira, R; Takahashi, RN; Canteras, NS
      Memory disruption in rats with nigral lesions induced by MPTP: a model forearly Parkinson's disease amnesia

      BEHAVIOURAL BRAIN RESEARCH
    77. Chassain, C; Eschalier, A; Durif, F
      Assessment of motor behavior using a video system and a clinical rating scale in parkinsonian monkeys lesioned by MPTP

      JOURNAL OF NEUROSCIENCE METHODS
    78. Santiago, M; Machado, A; Cano, J
      Validity of a quantitative technique to study striatal dopaminergic neurodegeneration by in vivo microdialysis

      JOURNAL OF NEUROSCIENCE METHODS
    79. Bonny, JM; Durif, F; Bazin, JE; Touraille, E; Yelnik, J; Renou, JP
      Contrast optimization of Macaca mulatta basal ganglia in magnetic resonance images at 4.7 Tesla

      JOURNAL OF NEUROSCIENCE METHODS
    80. Bar-Gad, I; Ritov, Y; Bergman, H
      The neuronal refractory period causes a short-term peak in the autocorrelation function

      JOURNAL OF NEUROSCIENCE METHODS
    81. Mazzio, E; Huber, J; Darling, S; Harris, N; Soliman, KFA
      Effect of antioxidants on L-glutamate and N-methyl-4-phenylpyridinium ion induced-neurotoxicity in PC12 cells

      NEUROTOXICOLOGY
    82. Csernansky, JG
      Structural MRI as a tool for the study of neurotoxicity and neurodegenerative disorders

      JOURNAL OF ANALYTICAL TOXICOLOGY
    83. Lee, ESY; Charlton, CG
      1-Methyl-4-phenyl-pyridinium increases S-adenosyl-L-methionine dependent phospholipid methylation

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    84. Liou, HH; Chen, RC; Chen, THH; Tsai, YF; Tsai, MC
      Attenuation of paraquat-induced dopaminergic toxicity on the substantia nigra by (-)-deprenyl in vivo

      TOXICOLOGY AND APPLIED PHARMACOLOGY
    85. Cooper, AJ; Stanford, IM
      Dopamine D2 receptor mediated presynaptic inhibition of striatopallidal GABA(A) IPSCs in vitro

      NEUROPHARMACOLOGY
    86. Boyce, S; Rupniak, NMJ; Steventon, MJ; Iversen, SD
      Differential effects of D-1 and D-2 agonists in MPTP,treated primates: Functional implications for Parkinson's disease

      NEUROLOGY
    87. Wu, RM; Cheng, CW; Chen, KH; Lu, SL; Shen, DE; Ho, YF; Chern, HD
      The COMT L allele modifies the association between MAOB polymorphism and PD in Taiwanese

      NEUROLOGY
    88. Olanow, CW; Watts, RL; Koller, WC
      An algorithm (decision tree) for the management of Parkinson's disease (2001): Treatment guidelines

      NEUROLOGY
    89. Martel, F; Calhau, C; Soares-da-Silva, P; Azevedo, I
      Transport of [H-3]MPP+ in an immortalized rat brain microvessel endothelial cell line (RBE 4)

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    90. Vila, M; Jackson-Lewis, V; Vukosavic, S; Djaldetti, R; Liberatore, G; Offen, D; Korsmeyer, SJ; Przedborski, S
      Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    91. Millan, MJ; Cussac, D; Milligan, G; Carr, C; Audinot, V; Gobert, A; Lejeune, F; Rivet, JM; Brocco, M; Duqueyroix, D; Nicolas, JP; Boutin, JA; Newman-Tancredi, A
      Antiparkinsonian agent piribedil displays antagonist properties at native,rat, and cloned, human alpha(2)-adrenoceptors: Cellular and functional characterization

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    92. Gulwadi, AG; Korpinen, CD; Mailman, RB; Nichols, DE; Sit, SY; Taber, MT
      Dinapsoline: Characterization of a D-1 dopamine receptor agonist in a rat model of Parkinson's disease

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    93. Isin, EM; de Jonge, M; Castagnoli, N
      Studies on synthetic approaches to 1H- and 2H-indazolyl derivatives

      JOURNAL OF ORGANIC CHEMISTRY
    94. Levy, R; Dostrovsky, JO; Lang, AE; Sime, E; Hutchison, WD; Lozano, AM
      Effects of apomorphine on subthalamic nucleus and globus pallidus internusneurons in patients with Parkinson's disease

      JOURNAL OF NEUROPHYSIOLOGY
    95. Ishiwata, K; Koyanagi, Y; Abe, K; Kawamura, K; Taguchi, K; Saitoh, T; Toda, J; Senda, M; Sano, T
      Evaluation of neurotoxicity of TIQ and MPTP and of parkinsonism-preventingeffect of 1-MeTIQ by in vivo measurement of pre-synaptic dopamine transporters and post-synaptic dopamine D-2 receptors in the mouse striatum

      JOURNAL OF NEUROCHEMISTRY
    96. Ferger, B; Themann, C; Rose, S; Halliwell, B; Jenner, P
      6-Hydroxydopamine increases the hydroxylation and nitration of phenylalanine in vivo: implication of peroxynitrite formation

      JOURNAL OF NEUROCHEMISTRY
    97. Rathke-Hartlieb, S; Kahle, PJ; Neumann, M; Ozmen, L; Haid, S; Okochi, M; Haass, C; Schulz, JB
      Sensitivity to MPTP is not increased in Parkinson's disease-associated mutant alpha-synuclein transgenic mice

      JOURNAL OF NEUROCHEMISTRY
    98. Grunblatt, E; Mandel, S; Maor, G; Youdim, MBH
      Effects of R- and S-apomorphine on MPTP-induced nigro-striatal dopamine neuronal loss

      JOURNAL OF NEUROCHEMISTRY
    99. De Girolamo, LA; Hargreaves, AJ; Billett, EE
      Protection from MPTP-induced neurotoxicity in differentiating mouse N2a neuroblastoma cells

      JOURNAL OF NEUROCHEMISTRY
    100. Przedborski, S; Chen, QP; Vila, M; Giasson, BI; Djaldatti, R; Vukosavic, S; Souza, JM; Jackson-Lewis, V; Lee, VMY; Ischiropoulos, H
      Oxidative post-translational modifications of alpha-synuclein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease

      JOURNAL OF NEUROCHEMISTRY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 23/10/20 alle ore 10:12:35